Search by Content
Select Jurisdiction
Select Practice/Industry
January 5, 2017
On June 18, 2016, the Federal Department of Health published a Notice of Intent to amend the Food and Drug Regulations and the Medical Devices Regulations to implement key authorities under Vanessa's Law...
January 5, 2017
Health Canada is seeking consultation on new standards for self-care products, over-the-counter drugs, natural health products and cosmetics ...
September 28, 2016
On January 21, 2016, various hospitals, natural health product manufacturers, physicians and pharmaceutical companies found themselves specifically named by Health Canada in a published list of health product advertising complaints ...
September 28, 2016
The Strategic Plan comprises a fresh vision, a revised mission statement and four new strategic objectives ...
March 1, 2016
The roles and responsibilities of the legal representative set out under Clinical Trials Directive 2001/20/EC are likely to change under the new Clinical Trials Regulation 536/2014.
March 1, 2016
The Canadian Intellectual Property Office has issued a revised guidance which provides clear instructions on how to approach medical use claims and determine whether such claims are eligible for patent protection.
October 7, 2015
If ratified, key intellectual property provisions in the Canada-EU trade pact will provide additional protection for innovative pharmaceutical products.
September 29, 2015
The proposed European regulatory regime will merge the directives on Medical Devices and Active Implantable Medical Devices into a single regulation and wholly replace the current regulation on In Vitro Diagnostic Medical Devices.
September 16, 2015
Analysis of the revocation of a company's drug patent and other key court rulings and updates on corporate and commercial matters
June 24, 2014
An overview of how and where regulatory controls apply to medical devices in India. Plus: key judgements passed by the Hon’ble Supreme Court; changes in corporate and commercial matters; and case laws in indirect taxation.
July 10, 2013
Judging by the attendance of healthcare providers at the Arab Health trade fair in Dubai in February 2013 it is clear that there is keen …
July 8, 2013
China is encouraging foreign investment into the pharmaceutical distribution industry by lifting previously entrenched barriers in ‘restricted’ categories in the field. Given that the government is additionally taking steps to reduce drug prices down the distribution chain, foreign manufacturers are electing to cut out the middleman and establish their own distribution business with a view to maxing out on profits. Jack Wang and Ma Ya of Freshfields Bruckhaus Deringer take us through the government’s efforts to boost foreign investment and consolidate the drug distribution industry in the PRC.
June 17, 2011
Offering huge potential for expansion and returns, almost every active economy in Asia is making efforts to actively develop a niche in the life sciences industry. In ‘Asia’s winning formula’ Asian-Counsel discusses how countries are positioning themselves to carve out niches in this area of living jurisprudence. The report also features expert articles focussing on particular developments in China, Japan, India and Singapore.